Skip to main content
OpenTrials
Completed

NCT Number: NCT03473028

Transvaginal Ultrasonography Guided Embryo Transfer

to evaluate the value of using transvaginal ultrasound guided embryo transfer in obese patients undergoing in vitro fertilization.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Infertility, Female Body Weight Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Genital Diseases Genital Diseases, Female Infertility Nutrition Disorders Nutritional and Metabolic Diseases Obesity Overnutrition Overweight Pathological Conditions, Signs and Symptoms Signs and Symptoms Urogenital Diseases

Age range

25 year–40 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Kasr El Ainiy Hospital

Cairo, 11562, Egypt

About this study

The 800 participants with body mass index more than 30kg/m2 were randomly allocated to two groups of equal size using an automated web-based randomization system. The first group 400 patient undergoing the transabdominal-guided embryo transfer, the second group 400 patient undergoing transvaginal-guided embryo transfer.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • BMI more than 35, good ovarian reserve, unexplained infertility more than 3 years.

Exclusion criteria

  • severe male factor of infertility,uterine factor of infertility excluded by ultrasonography and hysteroscopy ,ovarian endometrioma or patients with poly cystic ovary syndrome, obesity caused by abnormal endocrine function (thyroid or adrenal disorder)

Treatment and study plan

transabdominal ultrasound guided embryo transfer

Procedure

400 female with body mass index more than 30undergo transabdominal ultrasound guided embryo transfer

transvaginal ultrasound guided embryo transfer

Procedure

400 female with body mass index more than 30 undergo transvaginal ultrasound guided embryo transfer

Primary outcomes

  1. clinical pregnancy rate'

    Time frame: 4 weeks following embryo transfer

    the presence of at least one intrauterine gestational sac with viable fetus.

Secondary outcomes

  1. live birth rate

    Time frame: immediately following delivery

    delivery of a living baby

Sponsors and collaborators

Lead sponsor

Kasr El Aini Hospital

Other

Registry information

Official study title

Could Transvaginal Ultrasonography Guided Embryo Transfer Improves Pregnancy Outcome in Obese Patients Undergoing Intracytoplasmic Sperm Inoculation? Randomized Controlled Study

Important dates

Study start
2018
Primary completion
2021
Study completion
2021
First posted
Mar 21, 2018
Registry last updated
Apr 8, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.